share_log
Benzinga ·  May 6 16:03
Corvus Pharma Expects FY24 Net Cash Used In Operating Activities ~$24M-$27M, Resulting In Projected Cash Balance Of $31M-$34M At Dec. 31, 2024; Expects Cash To Find Operations Into Q4 2025
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment